GlaxoSmithKline (NYSE: GSK) and Flamel Technologies (Nasdaq: FLML) announced FDA approval of once-a-day Coreg CR extended-release capsules, for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE